Sanofi, DNDi Announce Three-Year Research Collaboration For Neglected Tropical Diseases

The pharmaceutical company Sanofi and the Drugs for Neglected Diseases initiative (DNDi) on Monday announced a three-year research collaboration to develop drugs for nine neglected tropical diseases, RTTNews reports. The diseases include leishmaniasis, Chagas disease, human African trypanosomiasis, lymphatic filariasis, onchocerciasis, soil-transmitted helminthiasis, and dracunculiasis, fascioliasis, and schistosomiasis (5/30). According to a joint press release (.pdf), “The public sector will benefit from the drugs developed through this agreement under the best possible conditions to ease access for patients in all endemic countries, irrespective of their level of economic development” (5/30).